Sarita Prabhakaran

553 total citations
29 papers, 361 citations indexed

About

Sarita Prabhakaran is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Sarita Prabhakaran has authored 29 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Sarita Prabhakaran's work include Occupational and environmental lung diseases (7 papers), Genetic factors in colorectal cancer (5 papers) and Medical Imaging and Pathology Studies (5 papers). Sarita Prabhakaran is often cited by papers focused on Occupational and environmental lung diseases (7 papers), Genetic factors in colorectal cancer (5 papers) and Medical Imaging and Pathology Studies (5 papers). Sarita Prabhakaran collaborates with scholars based in Australia, Saudi Arabia and Ireland. Sarita Prabhakaran's co-authors include Khawla S. Al‐Kuraya, Fouad Al‐Dayel, Shaham Beg, Zeenath Jehan, Abdul K. Siraj, Nasser Al‐Sanea, Shahab Uddin, Prashant Bavi, Rong Bu and Sonja Klebe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Cancer Research.

In The Last Decade

Sarita Prabhakaran

26 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarita Prabhakaran Australia 11 183 166 114 108 87 29 361
Zhengfu Fan China 11 167 0.9× 142 0.9× 155 1.4× 44 0.4× 71 0.8× 34 347
Laia Perez‐Roca Spain 9 137 0.7× 212 1.3× 197 1.7× 41 0.4× 124 1.4× 11 393
Marc Tänzer Germany 7 144 0.8× 175 1.1× 47 0.4× 89 0.8× 125 1.4× 7 325
Jae Sook Sung South Korea 13 194 1.1× 239 1.4× 173 1.5× 58 0.5× 194 2.2× 31 436
Xin-Jun Dong China 8 164 0.9× 297 1.8× 96 0.8× 35 0.3× 72 0.8× 12 418
Woody Han United States 6 141 0.8× 188 1.1× 77 0.7× 32 0.3× 52 0.6× 8 345
Charles Ginther United States 4 202 1.1× 294 1.8× 98 0.9× 65 0.6× 104 1.2× 6 430
Saravut J. Weroha United States 8 136 0.7× 223 1.3× 94 0.8× 34 0.3× 85 1.0× 19 349
Cristina Niccoli Italy 11 150 0.8× 156 0.9× 140 1.2× 46 0.4× 129 1.5× 19 393
Zhenchong Xiong China 12 243 1.3× 224 1.3× 105 0.9× 60 0.6× 206 2.4× 27 498

Countries citing papers authored by Sarita Prabhakaran

Since Specialization
Citations

This map shows the geographic impact of Sarita Prabhakaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarita Prabhakaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarita Prabhakaran more than expected).

Fields of papers citing papers by Sarita Prabhakaran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarita Prabhakaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarita Prabhakaran. The network helps show where Sarita Prabhakaran may publish in the future.

Co-authorship network of co-authors of Sarita Prabhakaran

This figure shows the co-authorship network connecting the top 25 collaborators of Sarita Prabhakaran. A scholar is included among the top collaborators of Sarita Prabhakaran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarita Prabhakaran. Sarita Prabhakaran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Logan, Jessica M., Alexandra Sorvina, I. R. Johnson, et al.. (2024). Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers. Scientific Data. 11(1). 852–852. 2 indexed citations
3.
Prabhakaran, Sarita, Ashley M. Hopkins, Benjamin S.‐Y. Ung, et al.. (2023). Insights into Melanoma Clinical Practice: A Perspective for Future Research. Cancers. 15(18). 4631–4631. 3 indexed citations
4.
Thomas, E, et al.. (2023). Molecular Characterization of Testicular Mesothelioma and the Role of Asbestos as a Causative Factor. Archives of Pathology & Laboratory Medicine. 147(12). 1446–1450. 6 indexed citations
5.
Logan, Jessica M., Alexandra Sorvina, Sarita Prabhakaran, et al.. (2023). Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(4). 723–728. 1 indexed citations
6.
Prabhakaran, Sarita, Alexandra Sorvina, Benjamin S.‐Y. Ung, et al.. (2022). Pitfalls in Cutaneous Melanoma Diagnosis and the Need for New Reliable Markers. Molecular Diagnosis & Therapy. 27(1). 49–60. 11 indexed citations
7.
Prabhakaran, Sarita, et al.. (2021). Progression of Well-Differentiated Papillary Mesothelial Tumour to Mesothelioma in a Patient with Ehlers Danlos Syndrome. SHILAP Revista de lepidopterología. 2(4). 306–311.
8.
Prabhakaran, Sarita, et al.. (2020). The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas. Human Pathology. 105. 1–8. 21 indexed citations
9.
Prabhakaran, Sarita, et al.. (2019). <p>A comparison of diagnostic panels in the immunohistochemical analysis of lung cancer</p>. Volume 11. 7–15. 2 indexed citations
10.
Klebe, Sonja, Sarita Prabhakaran, Sarah J. Moore, et al.. (2018). Pleural malignant mesothelioma versus pleuropulmonary synovial sarcoma: a clinicopathological study of 22 cases with molecular analysis and survival data. Pathology. 50(6). 629–634. 7 indexed citations
11.
Siraj, Abdul K., Shaham Beg, Zeenath Jehan, et al.. (2017). The role of HER2 overexpression in Middle Eastern papillary thyroid cancer. Translational Cancer Research. 6(2). 366–373. 2 indexed citations
12.
Prabhakaran, Sarita, et al.. (2017). The Effect of Aquaporin 1-Inhibition on Vasculogenic Mimicry in Malignant Mesothelioma. International Journal of Molecular Sciences. 18(11). 2293–2293. 11 indexed citations
13.
Siraj, Abdul K., Sarita Prabhakaran, Prashant Bavi, et al.. (2015). Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer. Cancer. 121(11). 1762–1771. 31 indexed citations
14.
Beg, Shaham, Abdul K. Siraj, Sarita Prabhakaran, et al.. (2015). Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer. Breast Cancer Research and Treatment. 151(3). 541–553. 44 indexed citations
15.
Beg, Shaham, Abdul K. Siraj, Sarita Prabhakaran, et al.. (2015). Molecular markers and pathway analysis of colorectal carcinoma in the Middle East. Cancer. 121(21). 3799–3808. 18 indexed citations
16.
Siraj, Abdul K., Rong Bu, Sarita Prabhakaran, et al.. (2014). A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma. Molecular Cancer. 13(1). 168–168. 35 indexed citations
17.
Bavi, Prashant, Zeenath Jehan, Rong Bu, et al.. (2013). ALK gene amplification is associated with poor prognosis in colorectal carcinoma. British Journal of Cancer. 109(10). 2735–2743. 34 indexed citations
18.
Bavi, Prashant, Shahab Uddin, Maqbool Ahmed, et al.. (2011). Bortezomib Stabilizes Mitotic Cyclins and Prevents Cell Cycle Progression via Inhibition of UBE2C in Colorectal Carcinoma. American Journal Of Pathology. 178(5). 2109–2120. 53 indexed citations
19.
Bavi, Prashant, Shahab Uddin, Rong Bu, et al.. (2011). Abstract 4412: Prognostic significance of NF-κB in Middle Eastern diffuse large B cell lymphoma and efficacy of NF-κB inhibition as a viable therapeutic target. Cancer Research. 71(8_Supplement). 4412–4412. 8 indexed citations
20.
Bavi, Prashant, Sarita Prabhakaran, Jehad Abubaker, et al.. (2010). Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations. Molecular Cancer. 9(1). 203–203. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026